Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT04862949 Completed - Clinical trials for Advanced Hepatocellular Carcinoma

Organ-specific Responses to Atezolizumab Plus Bevacizumab in Advanced HCC

Start date: May 1, 2021
Phase:
Study type: Observational

Hepatocellular carcinoma (HCC) is one of the most frequent causes of cancer-related deaths globally and in Korea. Many patients diagnosed at advanced stage, and systemic therapy is mainstay of treatment in patients with advanced HCC. However, immune-checkpoint inhibitor (ICI) monotherapy did not significantly improve overall survival in phase III studies. According to previous retrospective analyses, ICI treatment in advanced HCC showed different organ-specific responses. The intrahepatic HCC was the least responsive organ to ICI treatment. The failure of phase III trials of ICI monotherapy may have been attributed to different organ-specific response pattern of ICIs. Combination of atezolizumab plus bevacizumab is expected to overcome the immunosuppressive microenvironment of liver and may enhance intrahepatic response of ICI.

NCT ID: NCT04862091 Completed - Clinical trials for Metastatic Castration-resistant Prostate Cancer (mCRPC)

Comparative Study of Abiraterone Acetate Tablets (I) or ZYTIGA® in Patients With Metastatic Castration-resistant Prostate Cancer

Start date: April 23, 2021
Phase: Phase 2
Study type: Interventional

To evaluate whether the efficacy of the abiraterone acetate tablets (I) is comparable to that of the ZYTIGA®) by comparing the serum testosterone concentrations on Day 9 and/or Day 10 after oral administration of the two formulations in patients with metastatic castration-resistant prostate cancer (mCRPC).

NCT ID: NCT04862013 Completed - Clinical trials for Anterior Cruciate Ligament Injuries

Return to Sports After ACLR

RTSACL
Start date: June 1, 2021
Phase:
Study type: Observational

Patients who were surgically treated with ACL reconstruction at a single clinic between 2013 and 2018 will be approached by a questionnaire regarding their return to sport after surgery. Questions will focus on the timepoint of the return, subsequent injuries, and the impact of the initial injury on the life of the patients. In addition, existing clinical data from the baseline visit and from the follow-up visits offered routinely to the patient will be used.

NCT ID: NCT04861337 Completed - Clinical trials for Postoperative Nausea and Vomiting

Remimazolam and Postoperative Nausea and Vomiting in High-risk Patients

Start date: May 19, 2021
Phase: Phase 4
Study type: Interventional

This trial aims to explore whether the intraoperative use of remimazolam can reduce the incidence of postoperative nausea and vomiting (PONV) in high-risk patients. According to the Apfel's simplified score, patients with 3 or more of the following factors are at high risk of postoperative nausea and vomiting (PONV), i.e., women, non-smokers, history of PONV, and postoperative use of opioids.

NCT ID: NCT04861324 Completed - Type 2 Diabetes Clinical Trials

Effects of a Lifestyle Intervention on Gestational Diabetes Management

Start date: April 28, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the effects of nutrition education focusing on colorful fruit and vegetable intake with after-meal physical activity guidance on glycemic control and complications in women with gestational diabetes and pre-gestational diabetes.

NCT ID: NCT04860700 Completed - Clinical trials for Malignant Paraganglioma

The Efficacy and Safety of Anlotinib in Patients With Metastatic Pheochromocytoma or Paraganglioma

Start date: April 30, 2021
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well anlotinib hydrochloride works in treating patients with metastatic pheochromocytoma or paraganglioma. Anlotinib hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor.

NCT ID: NCT04859322 Completed - Clinical trials for Non-Alcoholic Fatty Liver Disease

The Effect of Lifestyle-induced Hepatic Steatosis on Glucagon-stimulated Amino Acid Turnover

Start date: February 8, 2021
Phase: N/A
Study type: Interventional

Many patients with type 2 diabetes exhibit elevated plasma concentrations of the glucose-mobilising pancreatic hormone glucagon; i.e. hyperglucagonaemia. This contributes to the hyperglycaemic state of the patients and is considered an important component in the pathophysiology of type 2 diabetes; but the mechanisms underlying this phenomenon remain unclear. The liver constitutes the main target organ of glucagon, and studies have shown that hyperglucagonaemia goes hand in hand with hyperaminoacidaemia and that both are associated with non-alcoholic fatty liver disease (NAFLD), independently of the presence of type 2 diabetes. In line with this, several recent studies support the existence of a feedback-cycle between the liver and the pancreatic alpha cells, governed by circulating glucagon and amino acids. The investigators hypothesise that the presence of hepatic steatosis results in hepatic glucagon resistance at the level of amino acid turnover, i.e. impaired glucagon-induced suppression of circulating amino acid concentrations. If this hypothesis proves correct, it would establish build-up of fat in the liver as a core mechanism underlying hyperglucagonaemia and, since the hyperglucagonemia is at least partly responsible for the fasting hyperglycaemia, as an important contributor to the hyperglycaemia of type 2 diabetes.

NCT ID: NCT04859140 Completed - Health Behavior Clinical Trials

Selective Effect of Foam Rolling and Manual Massage

AUTOMASSEEG
Start date: April 1, 2021
Phase: N/A
Study type: Interventional

The present double-blinded randomized controlled design aims at comparing the effects of a full-body manual massage and foam rolling intervention. Sixty-five healthy individuals were randomly allocated to foam rolling, manual massage or a control intervention consisting in an autogenic relaxation routine.

NCT ID: NCT04859036 Completed - Clinical trials for Autonomic Nervous System Imbalance

The Effect of Transcatheter Ventricular Septal Defect Closure on Heart Rate Variability Parameters

Start date: April 1, 2016
Phase:
Study type: Observational

In this study; we evaluated the heart rate variability parameters of pediatric patients whose VSDs were closed with the transcatheter method before and after, and compared with the control group.

NCT ID: NCT04858802 Completed - Clinical trials for Chronic Rhinosinusitis (Diagnosis)

A Clinical Evaluation of PROPEL® Contour Sinus Implant

EXPAND
Start date: May 12, 2021
Phase: N/A
Study type: Interventional

The objective of this study is to evaluate the efficacy of PROPEL Contour placement following an in-office frontal sinus balloon dilation (SBD) in patients with chronic rhinosinusitis (CRS)